CT
Celea Therapeutics
Biotechnology · Boston, Massachusetts, United StatesAbout
Its lead program is Deupirfenidone for IPF.
Company details may include data from People Data Labs, licensed CC BY 4.0.
Its lead program is Deupirfenidone for IPF.
Company details may include data from People Data Labs, licensed CC BY 4.0.